P/E ratio for ANI Pharmaceuticals (ANIP)

P/E ratio history for ANI Pharmaceuticals from 2001 to 2025

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Jazz Pharmaceuticals JAZZ	-27.3	-156.64%	🇮🇪 Ireland
Evoke Pharma EVOK	-4.37	-109.07%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	51.5	7.11%	🇮🇱 Israel
Pfizer PFE	14.6	-69.61%	🇺🇸 USA
Lannett Company LCI	-0.0271	-100.06%	🇺🇸 USA
Celldex Therapeutics CLDX	-7.67	-115.94%	🇺🇸 USA
Cardinal Health CAH	31.3	-35.01%	🇺🇸 USA
Novartis NVS	19.2	-60.01%	🇨🇭 Switzerland
Royalty Pharma RPRX	22.9	-52.51%	🇬🇧 UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.